{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:06:57Z","timestamp":1782522417798,"version":"3.54.5"},"reference-count":98,"publisher":"Harborside Press, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,6]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Opioid and benzodiazepine use and abuse is a national healthcare crisis to which patients with cancer are particularly vulnerable. Long-term use and risk factors for opioid and benzodiazepine use in patients with breast cancer is poorly characterized.<jats:bold>Methods:<\/jats:bold>We conducted a retrospective population-based study of patients with breast cancer diagnosed between 2008 and 2015 undergoing curative-intent treatment identified through the SEER-Medicare linked database. Primary outcomes were new persistent opioid use and new persistent benzodiazepine use. Factors associated with new opioid and benzodiazepine use were investigated by univariate and multivariable logistic regression.<jats:bold>Results:<\/jats:bold>Among opioid-na\u00efve patients, new opioid use was observed in 22,418 (67.4%). Of this group, 611 (2.7%) developed persistent opioid use at 3 months and 157 (0.7%) at 6 months after treatment. Risk factors for persistent use at 3 and 6 months included stage III disease (odds ratio [OR], 2.16; 95% CI, 1.49\u20133.12, and OR, 3.48; 95% CI, 1.58\u20137.67), surgery plus chemotherapy (OR, 1.44; 95% CI, 1.10\u20131.88, and OR, 2.28; 95% CI, 1.40\u20133.71), surgery plus chemoradiation therapy (OR, 1.47; 95% CI, 1.10\u20131.96, and OR, 2.34; 95% CI, 1.38\u20133.96), and initial tramadol use (OR, 2.66; 95% CI, 2.05\u20133.46, and OR, 3.12; 95% CI, 1.93\u20135.04). Among benzodiazepine-na\u00efve patients, new benzodiazepine use was observed in 955 (10.3%), and 111 (11.6%) developed new persistent use at 3 months. Tamoxifen use was statistically significantly associated with new persistent benzodiazepine use at 3 months.<jats:bold>Conclusions:<\/jats:bold>A large percentage of patients receiving curative-intent treatment of breast cancer were prescribed new opioids; however, only a small number developed new persistent opioid use. In contrast, a smaller proportion of patients received a new benzodiazepine prescription; however, new persistent use after completion of treatment was more likely and particularly related to concurrent treatment with tamoxifen.<\/jats:p>","DOI":"10.6004\/jnccn.2020.7612","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:49:23Z","timestamp":1609966163000},"page":"29-38","source":"Crossref","is-referenced-by-count":14,"title":["New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer"],"prefix":"10.6004","volume":"19","author":[{"given":"Mandy R.","family":"Sakamoto","sequence":"first","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Eguchi","sequence":"additional","affiliation":[{"name":"2Department of Health Systems, Management, and Policy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Azelby","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Diamond","sequence":"additional","affiliation":[{"name":"3Division of Medical Oncology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Fisher","sequence":"additional","affiliation":[{"name":"4Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia F.","family":"Borges","sequence":"additional","affiliation":[{"name":"3Division of Medical Oncology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy J.","family":"Bradley","sequence":"additional","affiliation":[{"name":"2Department of Health Systems, Management, and Policy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kabos","sequence":"additional","affiliation":[{"name":"3Division of Medical Oncology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref451","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.2009.23.8931","article-title":"Coprescription of tamoxifen and medications that inhibit CYP2D6","volume":"28","author":"Sideras","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.maturitas.2013.01.004","article-title":"Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly","volume":"74","author":"van Strien","year":"2013","journal-title":"Maturitas"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0194599818808513","article-title":"Short- and long-term opioid use in patients with oral and oropharynx cancer","volume":"160","author":"McDermott","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref921","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.cra508","article-title":"Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors","volume":"27","author":"Aubert","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006\u20132015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JOP.2017.026351","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update summary","volume":"13","author":"Hesketh","year":"2017","journal-title":"J Oncol Pract"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amjmed.2016.02.014","article-title":"A tool to assess risk of de novo opioid abuse or dependence","volume":"129","author":"Ciesielski","year":"2016","journal-title":"Am J Med"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"ref371","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.cra508","article-title":"Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors","volume":"27","author":"Aubert","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002\u20132014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"401\u2013","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/caac.21319","article-title":"American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline","volume":"66","author":"Runowicz","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2009.1568","article-title":"Prevalence of and factors associated with persistent pain following breast cancer surgery","volume":"302","author":"G\u00e4rtner","year":"2009","journal-title":"JAMA"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"e187399","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"705\u2013","DOI":"10.1200\/EDBK_180469","article-title":"Pain and opioids in cancer care: benefits, risks, and alternatives","volume":"37","author":"Bennett","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/a0035204","article-title":"Racial\/ethnic disparities in the assessment and treatment of pain: psychosocial perspectives","volume":"69","author":"Tait","year":"2014","journal-title":"Am Psychol"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/MLR.0000000000000444","article-title":"Analgesic access for acute abdominal pain in the emergency department among racial\/ethnic minority patients: a nationwide examination","volume":"53","author":"Shah","year":"2015","journal-title":"Med Care"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000330814","article-title":"Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients","volume":"81","author":"Vaidya","year":"2011","journal-title":"Oncology"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/pme.12787","article-title":"Prevalence and trends of concurrent opioid analgesic and benzodiazepine use among Veterans Affairs patients with post-traumatic stress disorder, 2003\u20132011","volume":"16","author":"Hawkins","year":"2015","journal-title":"Pain Med"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1526-4637.2011.01310.x","article-title":"Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States","volume":"13","author":"Meghani","year":"2012","journal-title":"Pain Med"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.2009.23.8931","article-title":"Coprescription of tamoxifen and medications that inhibit CYP2D6","volume":"28","author":"Sideras","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"24\u2013","DOI":"10.1200\/EDBK_100020","article-title":"Pain management for patients with advanced cancer in the opioid epidemic era","volume":"39","author":"Dalal","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2018.01.027","article-title":"Opioid use in gynecologic oncology in the age of the opioid epidemic: part I - effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review","volume":"149","author":"Lefkowits","year":"2018","journal-title":"Gynecol Oncol"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2016.0151","article-title":"Psychotropic and opioid medication use in older patients with breast cancer across the care trajectory: a population-based cohort study","volume":"14","author":"Syrowatka","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ajem.2019.06.014","article-title":"Racial and ethnic disparities in the management of acute pain in US emergency departments: meta-analysis and systematic review","volume":"37","author":"Lee","year":"2019","journal-title":"Am J Emerg Med"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10549-015-3497-x","article-title":"Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7\u20139 years after surgery: a nationwide prospective study of women treated for primary breast cancer","volume":"152","author":"Johannsen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"g1251","DOI":"10.1136\/bmj.g1251","article-title":"Rates and risk factors for prolonged opioid use after major surgery: population based cohort study","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"e187399","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"24\u2013","DOI":"10.1200\/EDBK_100020","article-title":"Pain management for patients with advanced cancer in the opioid epidemic era","volume":"39","author":"Dalal","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"g1251","DOI":"10.1136\/bmj.g1251","article-title":"Rates and risk factors for prolonged opioid use after major surgery: population based cohort study","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/caac.21319","article-title":"American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline","volume":"66","author":"Runowicz","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/PRS.0000000000003832","article-title":"Prescription opioid use among opioid-naive women Undergoing immediate breast reconstruction","volume":"140","author":"Marcusa","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amjmed.2016.02.014","article-title":"A tool to assess risk of de novo opioid abuse or dependence","volume":"129","author":"Ciesielski","year":"2016","journal-title":"Am J Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.seminoncol.2003.08.025","article-title":"Psychosocial and sexual functioning of survivors of breast cancer","volume":"30","author":"Kornblith","year":"2003","journal-title":"Semin Oncol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1073\/pnas.1516047113","article-title":"Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites","volume":"113","author":"Hoffman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/PRS.0000000000003832","article-title":"Prescription opioid use among opioid-naive women Undergoing immediate breast reconstruction","volume":"140","author":"Marcusa","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00520-011-1242-5","article-title":"Psychotropic medication during endocrine treatment for breast cancer","volume":"20","author":"de Bock","year":"2012","journal-title":"Support Care Cancer"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/a0035204","article-title":"Racial\/ethnic disparities in the assessment and treatment of pain: psychosocial perspectives","volume":"69","author":"Tait","year":"2014","journal-title":"Am Psychol"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1526-4637.2011.01310.x","article-title":"Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States","volume":"13","author":"Meghani","year":"2012","journal-title":"Pain Med"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.clpt.6100367","article-title":"Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response","volume":"83","author":"Goetz","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/JPR.S122853","article-title":"Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses","volume":"10","author":"Zin","year":"2017","journal-title":"J Pain Res"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JOP.2017.026351","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update summary","volume":"13","author":"Hesketh","year":"2017","journal-title":"J Oncol Pract"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/JPR.S122853","article-title":"Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses","volume":"10","author":"Zin","year":"2017","journal-title":"J Pain Res"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00520-011-1242-5","article-title":"Psychotropic medication during endocrine treatment for breast cancer","volume":"20","author":"de Bock","year":"2012","journal-title":"Support Care Cancer"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"e180919","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00520-017-3836-z","article-title":"A prospective study of docetaxel-associated pain syndrome","volume":"26","author":"Chiu","year":"2018","journal-title":"Support Care Cancer"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-017-4348-8","article-title":"Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens","volume":"165","author":"Tan","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/0284186X.2014.996662","article-title":"Pain management in cancer survivorship","volume":"54","author":"Kurita","year":"2015","journal-title":"Acta Oncol"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00520-017-3836-z","article-title":"A prospective study of docetaxel-associated pain syndrome","volume":"26","author":"Chiu","year":"2018","journal-title":"Support Care Cancer"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000330814","article-title":"Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients","volume":"81","author":"Vaidya","year":"2011","journal-title":"Oncology"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"401\u2013","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0194599818808513","article-title":"Short- and long-term opioid use in patients with oral and oropharynx cancer","volume":"160","author":"McDermott","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10549-015-3497-x","article-title":"Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7\u20139 years after surgery: a nationwide prospective study of women treated for primary breast cancer","volume":"152","author":"Johannsen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-017-4348-8","article-title":"Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens","volume":"165","author":"Tan","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/0284186X.2014.996662","article-title":"Pain management in cancer survivorship","volume":"54","author":"Kurita","year":"2015","journal-title":"Acta Oncol"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/pon.4218","article-title":"Sociodemographic inequalities in barriers to cancer pain management: a report from the American Cancer Society\u2019s Study of Cancer Survivor-II (SCS-II)","volume":"25","author":"Stein","year":"2016","journal-title":"Psychooncology"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","article-title":"Prevalence of undertreatment in cancer pain. A review of published literature","volume":"19","author":"Deandrea","year":"2008","journal-title":"Ann Oncol"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrn1914","article-title":"Cancer pain and its impact on diagnosis, survival and quality of life","volume":"7","author":"Mantyh","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","article-title":"Prevalence of undertreatment in cancer pain. A review of published literature","volume":"19","author":"Deandrea","year":"2008","journal-title":"Ann Oncol"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.seminoncol.2003.08.025","article-title":"Psychosocial and sexual functioning of survivors of breast cancer","volume":"30","author":"Kornblith","year":"2003","journal-title":"Semin Oncol"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2018.01.027","article-title":"Opioid use in gynecologic oncology in the age of the opioid epidemic: part I - effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review","volume":"149","author":"Lefkowits","year":"2018","journal-title":"Gynecol Oncol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2016.0151","article-title":"Psychotropic and opioid medication use in older patients with breast cancer across the care trajectory: a population-based cohort study","volume":"14","author":"Syrowatka","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/pme.12787","article-title":"Prevalence and trends of concurrent opioid analgesic and benzodiazepine use among Veterans Affairs patients with post-traumatic stress disorder, 2003\u20132011","volume":"16","author":"Hawkins","year":"2015","journal-title":"Pain Med"},{"key":"ref01","author":"Adler","year":"2008","journal-title":"Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrn1914","article-title":"Cancer pain and its impact on diagnosis, survival and quality of life","volume":"7","author":"Mantyh","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006\u20132015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.clinthera.2016.06.018","article-title":"Opioid use among metastatic prostate cancer patients with skeletal-related events","volume":"38","author":"Yaldo","year":"2016","journal-title":"Clin Ther"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/MLR.0000000000000444","article-title":"Analgesic access for acute abdominal pain in the emergency department among racial\/ethnic minority patients: a nationwide examination","volume":"53","author":"Shah","year":"2015","journal-title":"Med Care"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ajem.2019.06.014","article-title":"Racial and ethnic disparities in the management of acute pain in US emergency departments: meta-analysis and systematic review","volume":"37","author":"Lee","year":"2019","journal-title":"Am J Emerg Med"},{"key":"ref551","author":"Adler","year":"2008","journal-title":"Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15360288.2018.1479328","article-title":"Opioid and benzodiazepine relative use in breast cancer patients before, during, and after curative chemotherapy","volume":"32","author":"Yau","year":"2018","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"e180919","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15360288.2018.1479328","article-title":"Opioid and benzodiazepine relative use in breast cancer patients before, during, and after curative chemotherapy","volume":"32","author":"Yau","year":"2018","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1073\/pnas.1516047113","article-title":"Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites","volume":"113","author":"Hoffman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/pon.4218","article-title":"Sociodemographic inequalities in barriers to cancer pain management: a report from the American Cancer Society\u2019s Study of Cancer Survivor-II (SCS-II)","volume":"25","author":"Stein","year":"2016","journal-title":"Psychooncology"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"705\u2013","DOI":"10.1200\/EDBK_180469","article-title":"Pain and opioids in cancer care: benefits, risks, and alternatives","volume":"37","author":"Bennett","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.clpt.6100367","article-title":"Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response","volume":"83","author":"Goetz","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002\u20132014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.maturitas.2013.01.004","article-title":"Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly","volume":"74","author":"van Strien","year":"2013","journal-title":"Maturitas"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2009.1568","article-title":"Prevalence of and factors associated with persistent pain following breast cancer surgery","volume":"302","author":"G\u00e4rtner","year":"2009","journal-title":"JAMA"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.clinthera.2016.06.018","article-title":"Opioid use among metastatic prostate cancer patients with skeletal-related events","volume":"38","author":"Yaldo","year":"2016","journal-title":"Clin Ther"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/19\/1\/article-p29.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/19\/1\/article-p29.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T18:30:32Z","timestamp":1645209032000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/19\/1\/article-p29.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":98,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2020.7612","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]}}}